Robotic Surgery Faster for Laparoscopy in Endometrial CA

Share this content:
Robotic Surgery Faster for Laparoscopy in Endometrial CA
Robotic Surgery Faster for Laparoscopy in Endometrial CA

THURSDAY, Nov. 3, 2016 (HealthDay News) -- For patients with endometrial cancer, robotic-assisted laparoscopic surgery is faster than traditional surgery, according to a study published in the November issue of the American Journal of Obstetrics & Gynecology.

Minna M. Mäenpää, M.D., from Tampere University Hospital in Finland, and colleagues compared traditional and robotic-assisted laparoscopic surgery for endometrial cancer in a randomized controlled trial. One hundred one endometrial cancer patients were randomly allocated to hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy by robotic-assisted laparoscopic surgery or traditional laparoscopy; 99 patients were eligible for analysis.

The researchers found that the median operation time was 170 minutes in the traditional laparoscopy group and 139 minutes in the robotic surgery group (P < 0.001). The robotic surgery group also had a shorter total time spent in the operating room than the traditional group (197 versus 228 minutes; P < 0.001). There were five conversions to laparotomy in the traditional laparoscopy group versus none in the robotic surgery group (P = 0.027). The number of lymph nodes removed, bleeding, and length of postoperative hospital stay did not differ between the groups. There were no significant differences between the groups in intraoperative complications (P = 0.56) and major postoperative complications (P = 0.111).

"Robotic surgery offers an effective and safe alternative in the surgical treatment of endometrial cancer," the authors write.

One author spent four years as a proctor for robotic surgery.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »